CUA Call-to-Action: Advanced Prostate Cancer (mCSPC)
CUA Call-to-Action: Advanced Prostate Cancer (mCSPC)
Speakers: Andrea Kokorovic, Tamim Niazi, Ricardo Rendon & Christopher Wallis
Objectives
By the end of this program, participants can expect to:
- Review the general management of patients with mCSPC
- Discuss multi-disciplinary strategies in managing patients with mCSPC
- Understand the monitoring and system economic burden ARPIs
- Summarize the major adverse events associated with mPCa treatments
- Review the evidence-based strategies to mitigate the AEs associated with ADT and ARPIs
- Discuss the role of sequencing versus early intensification in patient outcomes
- Discuss the role of novel imaging modalities in mCSPC
- Review the role of radiation oncology in management of oligometastatic disease
ACCREDITATION
This activity is an Accredited Self-Assessment Program (Section 3) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada, and approved by CUA. You may claim a maximum of 1.5 hours of credit.
This program has received financial support from Bayer & Tolmar in the form of an educational grant.